Paul L. Nguyen mainly focuses on Prostate cancer, Internal medicine, Cancer, Surgery and Oncology. His Prostate cancer study integrates concerns from other disciplines, such as Prostate, Radiation therapy and Hazard ratio. His studies in Internal medicine integrate themes in fields like Gynecology and MEDLINE.
Paul L. Nguyen has included themes like Odds ratio, Body mass index, Logistic regression, Fatty acid synthase and Disease in his Cancer study. His study in Surgery is interdisciplinary in nature, drawing from both Nephrectomy and Risk factor. His studies deal with areas such as Incidence and Heart failure as well as Oncology.
Prostate cancer, Internal medicine, Oncology, Cancer and Radiation therapy are his primary areas of study. His Prostate cancer research is multidisciplinary, relying on both Prostate, Brachytherapy and Hazard ratio. Paul L. Nguyen combines subjects such as Interquartile range and Proportional hazards model with his study of Hazard ratio.
The concepts of his Internal medicine study are interwoven with issues in Gynecology and Surgery. Paul L. Nguyen has researched Oncology in several fields, including Clinical trial, Randomized controlled trial, Retrospective cohort study, Cohort and Comorbidity. His work deals with themes such as Odds ratio and Logistic regression, which intersect with Cancer.
His scientific interests lie mostly in Prostate cancer, Internal medicine, Oncology, Cancer and Radiation therapy. The Prostate cancer study combines topics in areas such as Prostate, Brachytherapy and Hazard ratio. The various areas that Paul L. Nguyen examines in his Hazard ratio study include Prostate-specific antigen and Urology.
His study in Internal medicine concentrates on Disease, Randomized controlled trial, Epidemiology, Confidence interval and Clinical trial. His study looks at the relationship between Oncology and fields such as MEDLINE, as well as how they intersect with chemical problems. His Prostatectomy research incorporates themes from Salvage therapy and Cohort.
Paul L. Nguyen mostly deals with Prostate cancer, Internal medicine, Oncology, Cancer and Radiation therapy. His Prostate cancer research includes themes of Prostate, Brachytherapy and MEDLINE. Hazard ratio, Disease, Randomized controlled trial, Clinical trial and Cohort are among the areas of Internal medicine where Paul L. Nguyen concentrates his study.
His research in Oncology intersects with topics in Meta-analysis, White, Gleason scores and Docetaxel. Paul L. Nguyen interconnects Interquartile range, Epidemiology, Retrospective cohort study and Intensive care medicine in the investigation of issues within Cancer. His study in Radiation therapy is interdisciplinary in nature, drawing from both Androgen and Cumulative incidence.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy
Paul L. Nguyen;Alphonse G. Taghian;Matthew S. Katz;Andrzej Niemierko.
Journal of Clinical Oncology (2008)
Marital Status and Survival in Patients With Cancer
Ayal A. Aizer;Ming Hui Chen;Ellen P. McCarthy;Mallika L. Mendu.
Journal of Clinical Oncology (2013)
Fatty acid synthase as a potential therapeutic target in cancer
Richard Flavin;Stephane Peluso;Paul L Nguyen;Massimo Loda.
Future Oncology (2010)
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
Paul L. Nguyen;Shabbir M.H. Alibhai;Shehzad Basaria;Anthony V. D’Amico.
European Urology (2015)
Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy
Nils D. Arvold;Alphonse G. Taghian;Andrzej Niemierko;Rita F. Abi Raad.
Journal of Clinical Oncology (2011)
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
Jing Ma;Haojie Li;Haojie Li;Ed Giovannucci;Ed Giovannucci;Lorelei Mucci.
Lancet Oncology (2008)
Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer: A Meta-analysis of Randomized Trials
Paul L. Nguyen;Youjin Je;Fabio A. B. Schutz;Karen E. Hoffman.
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
W. Robert Lee;James J. Dignam;Mahul B. Amin;Deborah W. Bruner.
Journal of Clinical Oncology (2016)
Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab
Toni K. Choueiri;Erica L. Mayer;Youjin Je;Jonathan E. Rosenberg.
Journal of Clinical Oncology (2011)
The role of focal therapy in the management of localised prostate cancer: a systematic review
Massimo Valerio;Massimo Valerio;Hashim U Ahmed;Mark Emberton;Nathan L Lawrentschuk.
European Urology (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: